Intermittent hypoxia (IH) in OSA promotes cancer progression by upregulating HIF-1α and transforming growth factor β1 (TGF-β1), which alter cytokine levels, increase TNF-α and IL-10, and decrease IL-17, suppressing antitumor immunity (41). This evidence concerns the gene IL17A and cancer.